濮阳东方医院治疗早泄技术值得信赖濮阳东方医院治阳痿可靠,濮阳东方男科医院口碑好价格低,濮阳市东方医院收费正规,濮阳东方医院割包皮评价比较好,濮阳东方男科医院割包皮口碑放心很好,濮阳东方医院男科电话咨询,濮阳市东方医院价格不贵

When those Amazon Prime Day orders start arriving, they will come in slightly different boxes.Amazon is encouraging people to get a little creative and have some seasonal fun before recycling those boxes.The box designs are part of the launch of a new augmented reality application by Amazon to create interactive and shareable experiences. Amazon describes it as a “fun way to reuse your Amazon boxes until you’re ready to drop them in the recycling bin.”The boxes coming soon have a white pumpkin and a QR code printed nearby. Images for the Amazon Augmented Reality app show drawings on the pumpkin seeming to come to life as a jack-o-latern.Images on the app description page show different box designs with a corgi dog and car option. No word on when those box designs could be hitting doorsteps.The boxes are also made with less material as part of Amazon’s ongoing effort to create less packaging. 912

While we’re still waiting on a comprehensive COVID-19 vaccine distribution plan, the Johns Hopkins Center for Health Security released an ethics framework Wednesday for who it says should be prioritized.There are two tiers of groups it says should go before the general public. No surprise, the first tier includes front line health care workers taking care of coronavirus patients, people over 65, those with underlying health conditions and their caregivers.Also noted are people who work in the vaccine industry and those who will be administering them. Also, school, food supply and public transportation workers.One issue with that first tier is that's a lot of people, more than 90 million by some estimates.“So, it’s quite possible when a vaccine is available, there won’t be enough available for everybody in this top tier and so there may need to be prioritization within this top tier,” said Dr. Eric Toner, senior scholar at the Johns Hopkins Center for Health Security.The second-tier group includes other health care workers, people living in remote locations without access to quality care, and other essential workers like delivery, military, and first responders.It also includes people who live in places where they can’t socially distance, so inmates and people in shelters.The framework also mentions this is a decision that shouldn't only be made by experts and officials.“The public needs an opportunity to weigh in on this because, after all, they are the ones who are the recipients of the vaccines and whether they get it or not,” said Toner.The good news is the scholars don't see cost as a barrier to the vaccine. And while a vaccine is the best hope for controlling the pandemic, it will not be a magic bullet right away.“If we have a vaccine sometime this winter that’s authorized, it will be many months before everybody has access to it,” said Toner.Some decisions about who gets the vaccine first can't be made until one is ready, because you need to know how it may impact groups like the elderly or pregnant women. 2055

White House physician Ronny Jackson will not return to his role as President Donald Trump's personal physician, Politico reports, citing two senior administration officials.The move comes after Jackson, a Navy rear admiral, withdrew his nomination for secretary of veterans affairs following a string of allegations that included he loosely handled prescription pain medications, was intoxicated during an overseas trip, and created a toxic work environment. Jackson has denied the allegations.The White House did not immediately respond to CNN's request for comment. 575

What makes a successful relationship? As some couples have found out during the pandemic, and researchers have scientifically discovered, it may boil down to how you engage with each other and how committed each partner is.A study published this week in the Proceedings of the National Academy of Sciences looked at responses from more than 11,000 romantic couples, tracked over about a year.“People’s own judgments about the relationship itself—such as how satisfied and committed they perceived their partners to be, and how appreciative they felt toward their partners—explained approximately 45% of their current satisfaction,” the study’s authors note. “The partner’s judgments did not add information, nor did either person’s personalities or traits.”Top relationship-specific predictors of relationship quality:Perceived partner commitmentAppreciationSexual satisfactionPerceived partner satisfactionConflictA person's own perception of their relationship accounted for about 45 percent of their current satisfaction with their relationship at the onset of a study, and about 18 percent by the end of the study.The study’s authors note the results are based on self-reporting and more study is needed over a longer period of time to see if these characteristics hold true over the long run.If you haven’t lately, it might be a good time to let your partner know that you appreciate them. 1402

While experts are encouraged by early vaccine data, many still say there is a way to go before life returns to normalcy."Operation Warp Speed," is a Trump administration effort to develop and deliver a safe and effective COVID-19 in the coming months. The administration's goal is to make initial doses available by January 2021.The vaccine will initially be rationed while drugmakers produce more doses. Healthcare workers, people in nursing homes, first responders and those with high-risk health conditions will likely be the first people eligible to receive the vaccine. According to Dr. Anthony Fauci, the director of the National Insitute for Allergies and Infectious Diseases, the rest of the general population won't be able to receive the vaccine until later in 2021.Pfizer and Moderna have both announced that their vaccines are on track for potential emergency authorization from the Food and Drug Administration. But there are several other candidates that could also get approval soon — and could potentially overtake the market.Both Pfizer's and Moderna's vaccine candidates require two shots, which need to be taken 28 days apart. But health experts believe that if a single-dose vaccine gets approval, it could quickly become the standard for worldwide vaccination."So, if you can get a vaccine out there that actually requires only one dose, it could quickly overtake the market," said Dr. Marcus Schabacker the President & CEO, of Emergency Care Research Institute.Health experts are also encouraged that there are several vaccine candidates in the final stages of testing — they believe that more potential vaccines reduce safety risks."We have a lot of people in the world. We need to vaccinate in different countries under different criteria, and you always run the risk that there's something in the Pfizer vaccine that someone's allergic to that isn't in the Madonna vaccine," said Dr. Jill Roberts, an associated professor as USF Health.One question that hasn't yet been answered is how the vaccines will stand up to the newly infected."So if you're turning positive today, we know you are exposed to somebody that had COVID, and we vaccinate you today — will that actually prevent you from developing severe disease?" Roberts said.Merck is another U.S. based pharmaceutical company that is working on a single-dose COVID-19 vaccine. That vaccine is currently in early testing overseas. 2422